HILS
Closed
Hillstream Biopharma Inc
2.875
-0.145 (-4.80%)
Last Update: 24 Nov 2023 17:30:00
Yesterday: 3.02
Day's Range: 2.8 - 2.9559
Send
sign up or login to leave a comment!
When Written:
0.8248
Hillstream Biopharma Inc is a privately held biotechnology company that focuses on the development of innovative cancer therapies. The company was founded in 2017 and is headquartered in Chapel Hill, North Carolina.
Hillstream Biopharma is focused on developing novel therapeutic antibodies that target cancer cells. The company's lead product candidate is HS-104, a monoclonal antibody that targets a specific protein found on the surface of cancer cells. HS-104 is currently in preclinical development and has shown promising results in animal models.
The company's team includes experienced biotech executives and scientists with expertise in cancer biology, drug development, and antibody engineering. Hillstream Biopharma has also established partnerships with leading academic institutions and research organizations to support its drug development programs.
Hillstream Biopharma is committed to advancing innovative cancer therapies that have the potential to improve patient outcomes and quality of life.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Hillstream Biopharma is focused on developing novel therapeutic antibodies that target cancer cells. The company's lead product candidate is HS-104, a monoclonal antibody that targets a specific protein found on the surface of cancer cells. HS-104 is currently in preclinical development and has shown promising results in animal models.
The company's team includes experienced biotech executives and scientists with expertise in cancer biology, drug development, and antibody engineering. Hillstream Biopharma has also established partnerships with leading academic institutions and research organizations to support its drug development programs.
Hillstream Biopharma is committed to advancing innovative cancer therapies that have the potential to improve patient outcomes and quality of life.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








